Basic Information
Basic information for C5orf64-216-13aa-2
Peptide Name C5orf64-216-13aa-2
Genome Position chr5:61758141-61758179[+]
Species Human
Peptide Sequence MTLIQCGKRLCRA
Peptide Length 13
Unique No (C5orf64-209-13aa-1,C5orf64-212-13aa-1,C5orf64-214-13aa-1,C5orf64-220-13aa-2,C5orf64-227-13aa-1,C5orf64-228-13aa-1)
Grand Average of Hydropathicity 0.2538
Relative Molecular Mass 1709.1
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000665180;C5orf64-216
Transcript Length 5946
Coding Ability 0.4391
DNA Sequence Corresponding to Peptide ATGACCCTGATTCAGTGTGGGAAGAGACTATGCAGGGCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :